Subscribe to Newsletter

Manufacture

Manufacture Contract Development Services

Partnerships To Be Precise

| Elizabeth Hickman, Dave Miller | 3 min read

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

Manufacture Advanced Medicine

Building a Resilient CGT Workforce

| Daniel Palmacci | 3 min read

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Manufacture Quality & Compliance

Innovating Pharmaceutical Packaging

| 3 min read

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements

Manufacture Technology and Equipment

The Myths and Reality of Hot Melt Extrusion

| Hibreniguss Terefe, Shahab Kashani Rahimi | 6 min read

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.

Manufacture Technology and Equipment

The Role of the Robot

| 3 min read

From cybersecurity challenges and AI-driven decision-making, to making mundane tasks more skillful, robotics is reshaping pharmaceutical operations.

Manufacture Facilities

FDA Warning Letters: March 2025 Edition

| Stephanie Vine | 3 min read

Indian CDMO denies manufacturing drug, contract testing lab pulled up for deficiencies, and lessons learned from Sanofi’s warning letter.

Manufacture Advanced Medicine

Partnership Cuts Cost of CAR T Manufacturing

| 4 min read

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that?

Manufacture Contract Development Services

Resilient Supply Chains in an Uncertain World; View From a CDMO

| 3 min read

From geopolitical conflicts to cyber threats, CDMOs must rethink resilience.

Manufacture Advanced Medicine

The Risks and Rewards of Rare Diseases

| Stephanie Vine | 4 min read

Bluebird bio’s financial situation is a stark reminder of the challenges of developing advanced therapies for rare diseases.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker